Ask the Experts: Clinical Case Studies Focusing on Non-statin Therapies for Treating Patients with Hypercholesterolemia
Registration closed - On-demand version of this activity coming in May.
Available at least 24 hours before webinar.
Activity Type: Application-based
CE Credits: 1.0
Activity Fee: Free of Charge
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Methods and CE Requirements
This is a live broadcast consisting of audio, presentation slides, and an activity evaluation tool. A live webinar brings the presentation to you. Listen to the speaker present in “real time” as you watch the slides on the screen. You will have the opportunity to ask the speaker questions at the end of the program. Please join the conference at least 5 minutes before the scheduled start time for important announcements.
To receive CE credit, participants must submit an enrollment code (announced during the webinar) and complete the evaluation. Participants will process CE credit online at ASHP's eLearning portal, CPE credit will be reported directly to CPE Monitor. Per ACPE, CPE credit must be claimed no later than 60 days from the date of the live activity or completion of a home study activity.
Target Audience
This continuing education activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small healthcare settings, ambulatory care clinics, managed care organizations, and academia. The activity is particularly beneficial for pharmacists, clinical specialists, managers, leaders, and educators who care for patients with hypercholesterolemia.
Activity Overview
This activity will focus on current issues related to the use of non-statin therapies for treating patients with hypercholesterolemia. The faculty will address the key issues and provide practice pearls for pharmacists.
The content for this activity is based on questions and comments from participants at a recent educational symposium on this topic. Time for additional questions from the webinar audience will be provided at the end of the presentation.
Learning Objectives
After the conclusion of this application-based educational activity, participants should be able to- Describe the evidence evaluating reduction in cardiovascular events with statin and non-statin combination therapy.
- Evaluate the use of non-statin therapies for the treatment of hypercholesterolemia in patients who cannot achieve desired LDL-C.
- Evaluate the use of non-statin therapies for the treatment of hypercholesterolemia in patients who report statin related muscle symptoms.
Faculty
Joseph Saseen, Pharm.D., BCPS, BCACP, FASHP, FCCP Activity Chair
Professor, Departments of Clinical Pharmacy and Family Medicine
Vice-Chair, Department of Clinical Pharmacy
University of Colorado School of Pharmacy
Aurora, Colorado
Joseph Saseen, Pharm.D., is Professor of Clinical Pharmacy and Family Medicine, and Vice-Chair of the Department of Clinical Pharmacy at the University of Colorado. He is Clinical Pharmacy Specialist in family medicine, Director of the PGY2 Ambulatory Care residency program and is a Board Certified Pharmacotherapy Specialist (BCPS) and Board Certified Ambulatory Care Pharmacist (BCACP).
Dr. Saseen received his Bachelor of Science degree in pharmacy and his Doctor of Pharmacy degree from the University at Buffalo. He completed a fellowship in ambulatory care research at the University of Colorado Health Sciences Center.
At the University of Colorado, Dr. Saseen participates in research related to the pharmacotherapy of chronic diseases (e.g., hypertension, dyslipidemia) and program grants related to the expansion of ambulatory care clinical services.
Dr. Saseen is a Fellow of the American Society of Health-System Pharmacists, American College of Clinical Pharmacy, and National Lipid Association. He is a past member and Chair of the Board of Pharmacy Specialties and is a board member of the National Lipid Association. He has several publications related to the pharmacotherapy of cardiovascular and was recipient of the American College of Clinical Pharmacy 2014 Education Award and the American Associations of Colleges of Pharmacy 2016 Teaching Innovations.
Kim K. Birtcher, Pharm.D, M.S., BCPS-AQ Cardiology, CLS, CDE, AACC, FNLA
Professor
University of Houston College of Pharmacy
Clinical Pharmacist
Kelsey-Seybold Clinic
Houston, Texas
Kim K. Birtcher, Pharm.D. is Clinical Professor at the University of Houston College of Pharmacy and clinical pharmacist at the Kelsey-Seybold Cardiology Clinic in Houston.
Dr. Birtcher received her Bachelor of Science degree in pharmacy and Master of Science degree in pharmacy administration from the University of Texas at Austin. She received her Doctor of Pharmacy degree from the University of Florida.
As a clinical pharmacist at the Kelsey-Seybold Cardiology Clinic in Houston, Texas, she is responsible for treating patients at the Secondary Prevention Lipid Clinic. Her teaching and research interests are in cardiovascular risk reduction and quality improvement initiatives.
Dr. Birtcher is a board certified pharmacotherapy specialist with additional qualifications in cardiology, a certified diabetes educator, and a clinical lipid specialist. She is an Associate of the American College of Cardiology (AACC) and a fellow of the National Lipid Association (FNLA). Dr. Birtcher is active in the American College of Cardiology (ACC), serving as the Co-Chair for the Cardiovascular Team Section’s Working Group for Clinical Pharmacists. She is a member of the ACC/AHA Task Force on Clinical Practice Guidelines and the past Co-Chair of the LDL: Address the Risk Initiative launched by the ACC.
Viewing Webinar as a Group
To view the webinar as a group, one person serving as the group coordinator should register. A few minutes before the webinar begins, the group coordinator should launch the webinar (using instructions from the email confirmation) and select the option to open audio via VoIP (Voice Over IP) or use a touch tone phone with the dial-in information. Each participant will process their own continuing education online.
Webinar System Requirements
Be sure to view the webinar system requirements for Windows, Mac, iOS, and Android prior to the activity.
The Changing Landscape of Hypercholesterolemia: The Emerging Role of Non-statin Therapies
A Symposium and Live Webinar conducted at the 51st ASHP Midyear Clinical Meeting and Exhibition
Mandalay Bay North Convention Center, Lower Level
Activity Overview
Given changing approaches to the treatment of hypercholesterolemia, which includes patients with familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease, this educational activity will review current and upcoming guideline recommendations and expert consensus for the treatment of this disorder in adults. With the recent approval of two PCSK9 inhibitors, the mechanism of action, indications, and clinical trial data on efficacy of these agents will be reviewed. Special considerations necessary for the procurement, storage, and administration of the PCSK9 inhibitors will also be described. Case studies will illustrate the appropriate use of non-statin therapies in the management of hypercholesterolemia.
Learning Objectives
After the conclusion of this application-based educational activity, participants should be able to
- Apply new guideline and expert consensus recommendations for the treatment of hypercholesterolemia in adults.
- Compare and contrast the mechanism of action of the PCSK9 inhibitors with statins and other non-statin drugs for the treatment of hypercholesterolemia.
- Analyze the potential role of non-statin drug therapies in the management of patients with hypercholesterolemia, including patients with familial hypercholesterolemia.
- Describe the role of the pharmacist in managing patients with hypercholesterolemia.
Agenda
11:30 a.m.-11:35 a.m.
Welcome and Introductions
Joe Saseen, Pharm.D., BCPS, BCACP, FASHP, FCCP
11:35a.m.-12:00 p.m.
Overview of Non-statin Therapies in the Management of Hypercholesterolemia: New Guideline Recommendations and Expert Consensus
Joe Saseen, Pharm.D., BCPS, BCACP, FASHP, FCCP
12:00 p.m.-12:50 p.m.
Case Studies in the Management of Hypercholesterolemia: The Role of Non-statin Therapies
Joe Saseen, Pharm.D., BCPS, BCACP, FASHP, FCCP
Kim Birtcher, M.S, Pharm.D, AACC, FNLA, BCPS-AQ Cardiology, CDE, CLS
12:50 p.m. -01:00 p.m.
Faculty Discussion and Audience Questions
All Faculty
Target Audience
This activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small healthcare settings, ambulatory care clinics, managed care organizations, and academia. The activity is particularly beneficial for pharmacists, clinical specialists, managers, leaders, and educators who care for patients with hypercholesterolemia.
Planned by ASHP Advantage and supported by educational funding provided by Amgen and an independent educational grant by Sanofi US and Regeneron Pharmaceuticals.
About This Initiative
Non-statin therapies have changed the landscape of treating patients with hypercholesterolemia This series of learning opportunities coordinated by ASHP Advantage focuses on current issues related to the use of non-statin therapies for treating patients with hypercholesterolemia. The learning opportunities provide both live and on-demand formats and they are designed to complement each other to illustrate factors to consider when treating patients with non-statin therapies to optimize LDL-C.
On-demand CE Activity
Ask the Experts: Clinical Case Studies Focusing on Non-statin Therapies for Treating Patients with Hypercholesterolemia
This one-hour activity will evaluate the use of non-statin therapies for treating dyslipidemia in patients who report statin related muscle symptoms or who cannot achieve desired LDL-C. Evidence evaluating reduction in cardiovascular events with statin and non-statin combination therapy will also be described.
On-demand CE Activity
More InformationDiscussion Guide
Download Discussion GuideeNewsletter
Features updates on new and emerging information about non-statin therapies, as well as key issues and practice pearls regarding their role in treating patients with hypercholesterolemia.
